RJA
LVGO

Raymond James & Associates’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

Raymond James & Associates’s Portfolio LVGO Stock Details LVGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-23,153
Closed -$3.24M – 3953
2020
Q3 		$3.24M Buy
23,153
+1,089
+5% +$133K ﹤0.01% 1461
2020
Q2 		$1.66M Buy
22,064
+13,499
+158% +$707K ﹤0.01% 1844
2020
Q1 		$244K Buy
+8,565
New +$222K ﹤0.01% 2908

Raymond James & Associates's LVGO Position: Q4 2020 in Review

Raymond James & Associates sold out of Livongo Health, Inc. Common Stock (LVGO) in Q4 2020, closing a stake of 23,153 shares — an estimated $3.24M sold.

Raymond James & Associates first reported a position in LVGO in Q1 2020 and held it in 3 quarters. The position peaked at $3.24M in Q3 2020. 0 funds tracked by Wall St. Rank hold LVGO as of Q4 2020.

  • Raymond James & Associates reported no remaining Livongo Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Raymond James & Associates sold 23,153 Livongo Health, Inc. Common Stock shares in Q4 2020, an estimated $3.24M.
  • Raymond James & Associates first reported a position in Livongo Health, Inc. Common Stock in Q1 2020 and held it in 3 quarters.
  • Raymond James & Associates's Livongo Health, Inc. Common Stock position peaked at $3.24M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q4 2020.

Based on Raymond James & Associates's 13F filing for Q4 2020, filed 12 Feb 2021.